Greystone Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638K | Buy |
3,435
+25
| +0.7% | +$4.64K | 0.11% | 76 |
|
|
2025
Q1 | $714K | Hold |
3,410
| – | – | 0.13% | 76 |
|
|
2024
Q4 | $606K | Buy |
+3,410
| New | +$606K | 0.11% | 80 |
|
|
2022
Q2 | – | Sell |
-34,951
| Closed | -$5.67M | – | 69 |
|
|
2022
Q1 | $5.67M | Sell |
34,951
-47,357
| -58% | -$7.68M | 1.43% | 38 |
|
|
2021
Q4 | $11.1M | Buy |
82,308
+15,419
| +23% | +$2.09M | 2.67% | 6 |
|
|
2021
Q3 | $7.22M | Sell |
66,889
-9,899
| -13% | -$1.07M | 2.14% | 9 |
|
|
2021
Q2 | $8.65M | Buy |
76,788
+696
| +0.9% | +$78.4K | 2.15% | 9 |
|
|
2021
Q1 | $8.74M | Buy |
76,092
+1,482
| +2% | +$170K | 2.2% | 8 |
|
|
2020
Q4 | $7.97M | Buy |
+74,610
| New | +$7.97M | 2.17% | 17 |
|